• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aspire Biopharma Holdings, Inc. - Common Stock (NQ:ASBP)

0.2122 -0.0091 (-4.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,174,775
Open 0.2100
Bid (Size) 0.2055 (300)
Ask (Size) 0.2079 (600)
Prev. Close 0.2213
Today's Range 0.2033 - 0.2160
52wk Range 0.1643 - 35.01
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
What's going on in today's after hours session ↗
April 27, 2026
Via Chartmill
Monday's session: most active stocks ↗
April 27, 2026
Via Chartmill

Performance

YTD
-96.1%
-96.1%
1 Month
-79.0%
-79.0%
3 Month
-90.0%
-90.0%
6 Month
-98.6%
-98.6%
1 Year
-98.5%
-98.5%

More News

Read More
News headline image
Aspire Biopharma Announces $5.0 Million Share Repurchase Program
April 27, 2026
Via ACCESS Newswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
April 22, 2026
Via Chartmill
Top movers in Tuesday's session ↗
April 21, 2026
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session. ↗
April 21, 2026
Via Chartmill
These stocks are moving in today's session ↗
April 21, 2026
Via Chartmill
News headline image
Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition
April 20, 2026
Via ACCESS Newswire
News headline image
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company's Brand Ambassador, Ashley Paulson, to Attempt Fastest 100-Mile Treadmill Run at 2026 Boston Marathon Expo
April 17, 2026
Via ACCESS Newswire
News headline image
Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue
April 16, 2026
Via ACCESS Newswire
News headline image
These stocks are moving in today's session ↗
April 15, 2026
Via Chartmill
Topics Artificial Intelligence
News headline image
Here are the top movers in Wednesday's session. ↗
April 15, 2026
Via Chartmill
Topics Artificial Intelligence
News headline image
Wednesday's session: gap up and gap down stocks ↗
April 15, 2026
Via Chartmill
Topics Artificial Intelligence
News headline image
These stocks are moving in today's pre-market session ↗
April 15, 2026
Via Chartmill
Topics Artificial Intelligence
News headline image
Aspire Biopharma's Buzz Bomb Caffeine Company Partners with Interwest Brokerage to Accelerate Retail Expansion
April 15, 2026
Via ACCESS Newswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
March 25, 2026
Via Chartmill
Wednesday's session: top gainers and losers ↗
March 25, 2026
Via Chartmill
News headline image
Aspire Biopharma's Subsidiary Announces Agreement with TruLife Distribution to Drive National Retail Expansion
March 19, 2026
Via ACCESS Newswire
News headline image
Aspire Biopharma's Subsidiary, Buzz Bomb Caffeine Company, Appoints John Choe as Western Sales Director
March 17, 2026
Via ACCESS Newswire
News headline image
Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026
March 12, 2026
Via ACCESS Newswire
News headline image
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack
March 10, 2026
Via ACCESS Newswire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
March 06, 2026
Via Chartmill
News headline image
Aspire Biopharma Partners with Microsize to Develop Rapid-delivery Sublingual Powder Formulation of Alprazolam for Faster Anxiety Relief
March 03, 2026
Via ACCESS Newswire
News headline image
Aspire Biopharma's Buzz Bomb(TM) Caffeine Company Achieves Record Social Media Growth and Sales Surge Following World-Record Marathon Sponsorship
February 25, 2026
Via ACCESS Newswire
News headline image
Aspire Biopharma Regains Full Compliance with Nasdaq Listing Requirements
February 20, 2026
Via ACCESS Newswire

Frequently Asked Questions

Is Aspire Biopharma Holdings, Inc. - Common Stock publicly traded?
Yes, Aspire Biopharma Holdings, Inc. - Common Stock is publicly traded.
What exchange does Aspire Biopharma Holdings, Inc. - Common Stock trade on?
Aspire Biopharma Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock?
The ticker symbol for Aspire Biopharma Holdings, Inc. - Common Stock is ASBP on the Nasdaq Stock Market
What is the current price of Aspire Biopharma Holdings, Inc. - Common Stock?
The current price of Aspire Biopharma Holdings, Inc. - Common Stock is 0.2122
When was Aspire Biopharma Holdings, Inc. - Common Stock last traded?
The last trade of Aspire Biopharma Holdings, Inc. - Common Stock was at 05/01/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap